Rep. Manny Cruz

Maddy summaryThis bill creates a new endometriosis task force within Massachusetts' Executive Office of Health and Human Services. The task force, composed of health officials, medical associations, patient advocates, and industry representatives, must annually develop summaries on research and care access, monitor endometriosis services, and create a strategic plan with specific recommendations to improve diagnosis, treatment, and research. It requires the task force to submit annual reports to the governor and state legislators by December 31 each year. The bill directly affects individuals with endometriosis by establishing a formal process to address gaps in their care and research.

Senate, October 9, 2025 -- The committee on Senate Ways and Means, to whom was referred the Senate Bill relative to menstrual product ingredient disclosure (Senate, No. 1483),- reports, recommending that the same ought to pass with an amendment substituting a new draft with the same title (Senate, No. 2641).

By Mr. DiDomenico, a petition (accompanied by bill, Senate, No. 118) of Sal N. DiDomenico, Carmine Lawrence Gentile, Joanne M. Comerford, Mark C. Montigny and other members of the General Court for legislation to lift kids out of deep poverty. Children, Families and Persons with Disabilities.

Maddy summaryHD 1552 requires shelters, schools, and correctional facilities to provide free disposable menstrual products (like pads, tampons, and liners) to menstruating individuals without stigma. It applies to temporary housing providers (e.g., domestic violence shelters, emergency hotels), all public primary/secondary schools, and correctional facilities (jails, prisons). The bill mandates these products be available in convenient, non-stigmatizing ways, such as in restrooms. This directly affects menstruating people experiencing homelessness, attending school, or in detention. The law creates a new requirement for these specific institutions to cover the cost of products.

Senate, October 9, 2025 -- The committee on Senate Ways and Means, to whom was referred the Senate Bill to increase access to disposable menstrual products (Senate, No. 2546),- reports, recommending that the same ought to pass with an amendment substituting a new draft with the same title (Senate, No. 2640).

Senate, July 10, 2025 -- The committee on Public Health to whom was referred the petition (accompanied by bill, Senate, No. 1549) of Patricia D. Jehlen, John F. Keenan, Michael J. Barrett, Patrick M. O'Connor and other members of the Senate for legislation to increase access to disposable menstrual products, report the accompanying bill (Senate, No. 2546).

By Ms. Lovely, a petition (accompanied by bill, Senate, No. 155) of Joan B. Lovely, Sean Garballey, Alyson M. Sullivan-Almeida, James K. Hawkins and other members of the General Court for legislation relative to supported decision-making agreements for certain adults with disabilities. Children, Families and Persons with Disabilities.

By Ms. Comerford, a petition (accompanied by bill, Senate, No. 1483) of Joanne M. Comerford, Rebecca L. Rausch, John F. Keenan, Jason M. Lewis and other members of the Senate for legislation relative to menstrual product ingredient disclosure. Public Health.

Maddy summaryThis bill requires manufacturers selling menstrual products (like tampons, pads, cups, and underwear) in Massachusetts to disclose all ingredients on product packaging and online. Labels must list ingredients in order of predominance using visible 10-point font, and manufacturers must update both packaging and online disclosures when ingredients change. The law applies to all manufacturers whose products are sold in the state, with violations punishable by a $1,000 fine per offense. It takes effect 12 months after passage and supplements existing labeling requirements.

By Ms. Lovely, a petition (accompanied by bill, Senate, No. 1168) of Joan B. Lovely, Peter J. Durant, Todd M. Smola, David T. Vieira and other members of the General Court for legislation to set rates for transcripts of notes and fees taken at a trial or hearing by a transcriber. The Judiciary.